TRELLUS HEALTH PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.55 GBX | -6.06% |
|
-6.06% | -52.31% |
| Apr. 24 | Transcript : Trellus Health plc, Q4 2023 Earnings Call, Apr 24, 2024 | |
| Apr. 23 | EARNINGS: Videndum warns on recovery; AB Dynamics expects profit beat | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Trellus Health plc is a United Kingdom-based health services company, which is engaged in providing solutions and services for chronic condition management. The Company is focused on chronic costly GI conditions that have high mental health burden, such as inflammatory bowel disease (IBD) which includes the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The Company has one division being the providing resilience-driven care for chronic conditions in the inflammatory bowel disease state. The Companyâs Trellus Elevate platform is a connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Trellus Elevateâs personalized health roadmaps include engaging lessons and skill-building techniques designed to empower individuals. The Companyâs wholly owned subsidiary is Trellus Health Inc.
Sector
Software
Calendar
2024-09-26
- Q2 2024 Earnings Release (Projected)
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -52.31% | 3.35M | |
| +10.78% | 3,096B | |
| +8.69% | 85.37B | |
| +4.02% | 77.1B | |
| -13.51% | 54.31B | |
| -22.61% | 47.92B | |
| +24.87% | 47.74B | |
| +19.76% | 42.15B | |
| +63.60% | 38.06B | |
| -9.93% | 24.73B |
- Stock Market
- Equities
- TRLS Stock
- News Trellus Health plc
- Former EKF Diagnostics COO Takes on Interim CFO Role at Trellus Health
